Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.
- DOI
- 10.1016/j.chest.2023.06.023
- Published
- 2023 Dec
- Container
- Chest
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.chest.2023.06.023,
title = {Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.},
author = {Fauvel C and Liu Y and Correa-Jaque P and Kanwar MK and Vizza CD and Lin S and Benza RL},
year = {2023},
journal = {Chest},
doi = {10.1016/j.chest.2023.06.023},
url = {https://doi.org/10.1016/j.chest.2023.06.023}
}RIS
TY - JOUR TI - Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial. AU - Fauvel C AU - Liu Y AU - Correa-Jaque P AU - Kanwar MK AU - Vizza CD AU - Lin S AU - Benza RL PY - 2023 JO - Chest DO - 10.1016/j.chest.2023.06.023 UR - https://doi.org/10.1016/j.chest.2023.06.023 ER -
APA
C, F., Y, L., P, C., MK, K., CD, V., S, L., & RL, B. (2023). Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.. Chest. https://doi.org/10.1016/j.chest.2023.06.023
Source records
- pubmed · retrieved 2026-09-26T03:50:23.179Z